Successful treatment of pulmonary inflammatory myofibroblastic tumor with platinum-pemetrexed: The first report of two cases

被引：4
作者：
Si, Xiaoyan [1 ]
Wang, Hanping [1 ]
Zhang, Xiaotong [1 ]
Wang, Mengzhao [1 ]
You, Yan [2 ]
Zhang, Li [1 ]
机构：
[1] Peking Union Med Coll Hosp, Dept Pulm & Crit Care Med, 1 Shuaifuyuan Wangfujing, Beijing 100730, Peoples R China
[2] Peking Union Med Coll Hosp, Dept Pathol, Beijing, Peoples R China
来源：
THORACIC CANCER | 2020年 / 11卷 / 08期
关键词：
Inflammatory myofibroblastic tumor; pemetrexed; platinum; CARE;
D O I：
10.1111/1759-7714.13520
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Pulmonary inflammatory myofibroblastic tumor (IMT) is a rare tumor. Here, we report two cases of pulmonary IMT successfully treated with platinum and pemetrexed. The results from this study suggest that platinum-pemetrexed might be an effective therapy in patients with IMT, but requires further investigation.
引用
收藏
页码：2339 / 2342
页数：4
相关论文
共 8 条
  • [1] How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature
    Alan, Ozkan
    Kuzhan, Okan
    Koca, Sinan
    Telli, Tugba Akin
    Tuylu, Tugba Basoglu
    Ercelep, Ozlem
    Filinte, Deniz
    Sengul, Yildiz
    Arikan, Huseyin
    Kaya, Serap
    Babacan, Nalan Akgul
    Dane, Faysal
    Yumuk, Perran Fulden
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (04) : 1011 - 1018
  • [2] Molecular Characterization of Inflammatory Myofibroblastic Tumors With Frequent ALK and ROS1 Gene Fusions and Rare Novel RET Rearrangement
    Antonescu, Cristina R.
    Suurmeijer, Albert J. H.
    Zhang, Lei
    Sung, Yun-Shao
    Jungbluth, Achim A.
    Travis, William D.
    Al-Ahmadie, Hikmat
    Fletcher, Christopher D. M.
    Alaggio, Rita
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (07) : 957 - 967
  • [3] ALK inhibition in two emblematic cases of pediatric inflammatory myofibroblastic tumor: Efficacy and side effects
    Brivio, Erica
    Zwaan, C. Michel
    [J]. PEDIATRIC BLOOD & CANCER, 2019, 66 (05)
  • [4] Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
    Lovly, Christine M.
    Gupta, Abha
    Lipson, Doron
    Otto, Geoff
    Brennan, Tina
    Chung, Catherine T.
    Borinstein, Scott C.
    Ross, Jeffrey S.
    Stephens, Philip J.
    Miller, Vincent A.
    Coffin, Cheryl M.
    [J]. CANCER DISCOVERY, 2014, 4 (08) : 889 - 895
  • [5] Maruyama Y, 2017, MOL CLIN ONCOL, V7, P521, DOI 10.3892/mco.2017.1383
  • [6] Long-Term and Low-Grade Safety Results of a Phase III Study (PARAMOUNT): Maintenance Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-Small-Cell Lung Cancer
    Pujol, Jean-Louis
    Paz-Ares, Luis
    de Marinis, Filippo
    Dediu, Mircea
    Thomas, Michael
    Bidoli, Paolo
    Corral, Jesus
    San Antonio, Belen
    Chouaki, Nadia
    John, William
    Zimmermann, Annamaria
    Visseren-Grul, Carla
    Gridelli, Cesare
    [J]. CLINICAL LUNG CANCER, 2014, 15 (06) : 418 - 425
  • [7] Clinical and Histopathologic Correlates and Management Strategies for Inflammatory Myofibroblastic tumor of the lung. A case series and review of the literature
    Sagar, Ala Eddin S.
    Jimenez, Carlos A.
    Shannon, Vickie R.
    [J]. MEDICAL ONCOLOGY, 2018, 35 (07)
  • [8] Telugu RB, 2017, J PATHOL TRANSL MED, V51, P255, DOI 10.4132/jptm.2017.01.12
1